Nimesulide prevents lipopolysaccharide-induced elevation in plasma tumor necrosis factor-α in rats
- 30 October 1998
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 63 (23), PL323-PL327
- https://doi.org/10.1016/s0024-3205(99)80011-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The Future Role of Anti-Tumour Necrosis Factor (TNF) Products in the Treatment of Rheumatoid ArthritisDrugs, 1998
- Soluble Tumor Necrosis Factor ? Receptor Prevents Decrease of Body Temperature in Mice Treated with Indomethacin and LipopolysaccharideAnnals of the New York Academy of Sciences, 1997
- Studies on the Role of Tumor Necrosis Factor ? in the Responses to Bacterial Pyrogenic StimuliAnnals of the New York Academy of Sciences, 1997
- The Tumor Necrosis Factor Ligand and Receptor FamiliesNew England Journal of Medicine, 1996
- Actions of cytokines in relation to arachidonic acid metabolism and eicosanoid productionProstaglandins, Leukotrienes & Essential Fatty Acids, 1996
- Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study GroupPublished by American Medical Association (AMA) ,1995
- NimesulideDrugs, 1994
- The Role of Interleukins and Nitric Oxide in the Mediation of Inflammatory Pain and its Control by Peripheral AnalgesicsDrugs, 1993
- Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.The Journal of Experimental Medicine, 1991
- NimesulideDrugs, 1988